Pharm

Nebivolol

search

Nebivolol, Bystolic

  • See Also
  1. Beta Blocker
  2. Labetalol
  3. Carvedilol
  • Indications
  1. Hypertension
  • Contraindications
  1. Severe Liver Impairment
  • Mechanism
  1. Third generation Beta Blocker (Beta-1 Selective) with vasodilatory properties (nitric oxide release)
  2. Unique vasodilator mechanism with nitric oxide release via Beta-3 Agonist activity
    1. Relaxes vascular Smooth Muscle resulting in vasodilation
    2. Contrast with Labetalol and Carvedilol which exert vasodilation via alpha-1 activity
  • Dosing
  1. Start: 5 mg orally daily
    1. Start at 2.5 mg in hepatic Impairment or CrCl <30 ml/min
  2. Maximum: 40 mg/day
  • Adverse Effects
  1. See Beta Blocker
  • Safety
  1. Pregnancy Category C
  2. Avoid in Lactation
  • Resources
  1. Nebivolol (DailyMed)
    1. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=202d5142-6180-4d48-9a9f-1bd6992fc49b
  • References
  1. (2019) Presc Lett, Resource #350503, Comparison of Oral Beta Blockers
  2. (2020) Med Lett Drugs Ther 62(1598): 73-80
  3. Olson (2020) Clinical Pharmacology, Medmaster Miami, p. 66-7
  4. Hamilton (2020) Tarascon Pocket Pharmacopoeia